Smith Group Asset Management’s Novavax NVAX Stock Holding History

Smith Group Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,840	Closed	-$118K	–	478
2016 Q3	$118K	Hold	2,840	–	–	﹤0.01%	296
2016 Q2	$413K	Sell	2,840 -37	-1%	-$4.24K	0.01%	193
2016 Q1	$299K	Buy	+2,877	New	+$309K	0.01%	179

Other funds holding NVAX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

QIM

Quantitative Investment Management Charlottesville, Virginia $963M AUM 12.95% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Smith Group Asset Management's NVAX Position: Q4 2016 in Review

Smith Group Asset Management sold out of Novavax (NVAX) in Q4 2016, closing a stake of 2,840 shares — an estimated $118K sold.

Smith Group Asset Management first reported a position in NVAX in Q1 2016 and held it in 3 quarters. The position peaked at $413K in Q2 2016. 142 funds tracked by Wall St. Rank hold NVAX as of Q4 2016.

Smith Group Asset Management reported no remaining Novavax position as of Q4 2016 after selling out during the quarter.
Smith Group Asset Management sold 2,840 Novavax shares in Q4 2016, an estimated $118K.
Smith Group Asset Management first reported a position in Novavax in Q1 2016 and held it in 3 quarters.
Smith Group Asset Management's Novavax position peaked at $413K in Q2 2016.
142 funds tracked by Wall St. Rank held Novavax as of Q4 2016.

Based on Smith Group Asset Management's 13F filing for Q4 2016, filed 31 Jan 2017.